Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoimmune diabetes in male NOD mice.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Autoimmunity

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/08916939908994763PMID 10435719
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice.

  1998cited by this paper
• Interleukin-4 Deficiency Does Not Exacerbate Disease in NOD Mice

  1998cited by this paper
• IL-12 down-regulates autoantibody production in mercury-induced autoimmunity.

  1998cited by this paper
• A distinct role for interleukin-13 in Th2-cell-mediated immune responses.

  1998cited by this paper
• Immunomodulation of murine experimental SLE-like disease by interferon-γ

  1998cited by this paper
• TGF-β1 Somatic Gene Therapy Prevents Autoimmune Disease in Nonobese Diabetic Mice

  1998cited by this paper
• Paradoxical Antidiabetogenic Effect of γ-Interferon in DP-BB Rats

  1998cited by this paper
• IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice.

  1997cited by this paper
• Deviation of pancreas‐infiltrating cells to Th2 by interleukin‐12 antagonist administration inhibits autoimmune diabetes

  1997cited by this paper
• Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.

  1997cited by this paper
• Genetic differences in immune reactivity to mercuric chloride (HgCl2): immunosuppression of H‐2d mice is mediated by interferon‐gamma (IFN‐γ)

  1997cited by this paper
• Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice.

  1996cited by this paper
• Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice

  1996cited by this paper
• Cytokines and the endocrine system. II. Roles in substrate metabolism, modulation of thyroidal and pancreatic endocrine cell functions and autoimmune endocrine diseases.

  1996cited by this paper
• Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice

  1996cited by this paper
• Protective major histocompatibility complex genes and the role of interleukin‐4 in collagen‐induced arthritis

  1996cited by this paper
• The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse.

  1996cited by this paper
• Human autoimmune diabetes mellitus: lessons from BB rats and NOD mice--Caveat emptor.

  1995cited by this paper
• Biphasic effect of interferon‐γ in murine collagen‐induced arthritis

  1995cited by this paper
• IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.

  1995cited by this paper
• Tolerance Induction as a Therapeutic Strategy for the Control of Autoimmune Endocrine Disease in Mouse Models

  1995cited by this paper
• Cytokine-binding proteins: stimulating antagonists.

  1995cited by this paper
• CD4 T cell development and cytokine polarization: an overview

  1995cited by this paper
• Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process

  1994cited by this paper
• Cytokines and natural regulators of cytokines.

  1994cited by this paper
• Immunoregulatory and Cytokine Imbalances in the Pathogenesis of IDDM: Therapeutic Intervention by Immunostimulation?

  1994cited by this paper
• Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous Leishmaniasis

  1994cited by this paper
• Protection from experimental autoimmune diabetes in the non‐obese diabetic mouse with soluble interleukin‐1 receptor

  1994cited by this paper
• Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4

  1994cited by this paper
• Role of IL-2 and IL-4 in exacerbations of murine antigen-induced arthritis.

  1994cited by this paper
• Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse.

  1994cited by this paper
• The effects of a monoclonal antibody to interferon‐γ on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT‐specific T cells

  1993cited by this paper
• Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice

  1993cited by this paper
• Distribution of interferon-gamma receptor in human tissues.

  1992cited by this paper
• Distribution of interferon‐γ receptor in human tissues

  1992cited by this paper
• Monoclonal anti-tumor necrosis factor antibody renders non-obese diabetic mice hypersensitive to irradiation and enhances insulitis development.

  1992cited by this paper
• Reduction in insulitis following administration of IFN-γ and TNF-α in the NOD mouse

  1991cited by this paper
• IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride.

  1991cited by this paper
• Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor.

  1991cited by this paper
• Reduction in insulitis following administration of IFN-gamma and TNF-alpha in the NOD mouse.

  1991cited by this paper
• Induction of experimental thyroiditis in mice by recombinant interferon gamma administration.

  1990cited by this paper
• Induction of experimental thyroiditis in mice by recombinant interferon γ administration

  1990cited by this paper
• The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms.

  1989cited by this paper
• Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice.

  1989cited by this paper
• In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

  1987cited by this paper
• The purification and characterization of rat gamma interferon by use of two monoclonal antibodies.

  1986cited by this paper
• Monoclonal antibodies against murine gamma interferon.

  1984cited by this paper
• Cloning and expression of murine immune interferon cDNA.

  1983cited by this paper

• Insulin Administration Confers Diabetes-Preventive Properties to NOD Mice Derived Dendritic Cells

  2007cites this paper
• Autoimmune Cholangitis in the SJL/J Mouse is Antigen Non-specific

  2002cites this paper
• A murine interleukin-4-Ig fusion protein regulates the expression of Th1- and Th2-specific cytokines in the pancreas of NOD mice.

  2002cites this paper
• Cytokines and Resistance to Organ Specific Autoimmune Disease

  2002cites this paper
• A Murine Interleukin-4-Ig Fusion Protein Regulates the Expression of Th1- and Th2-Specific Cytokines in the Pancreas of NOD Mice

  2002cites this paper
• Deutsches Diabetes-Forschungsinstitut an der Heinrich-Heine-Universität Düsseldorf Deutsches Diabetes-Zentrum Arbeitsgruppe Immun-Pathologie und Immun-Toxikologie

  2001cites this paper